Silicone Oil Microdroplets and Protein Aggregates in Repackaged Bevacizumab and Ranibizumab: Effects of Long-term Storage and Product Mishandling
Author(s) -
Lu Liu,
David A. Ammar,
Lindsey A. Ross,
Naresh Mandava,
Malik Y. Kahook,
John F. Carpenter
Publication year - 2010
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.10-6431
Subject(s) - bevacizumab , medicine , vial , silicone oil , compounding , chromatography , particle size , particle counter , ophthalmology , surgery , chemistry , materials science , pharmacology , aerosol , composite material , organic chemistry , chemotherapy
To quantify levels of subvisible particles and protein aggregates in repackaged bevacizumab obtained from compounding pharmacies, as well as in samples of bevacizumab and ranibizumab tested in controlled laboratory experiments.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom